K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Review labels

Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.

How it was studied

Design

Randomized controlled trial (classified by our AI screen)

Studied in

People

Main outcome

Health markers and function

Who paid for it

Funding

Funding not disclosed

Publication

Published

2017-01-01 · Am J Kidney Dis · vol. 42 · issue 1 · pp. 33–42

Publisher

Karger Publishers

Cited

29690 citations · more than 100% of similar papers · 1380.9× the field average

Impact

Top 10% most cited in its field

References

76 works

Access

Open access (journal) · CC-BY-NC-ND

Research areas

Magnesium in Health and Disease · Parathyroid Disorders and Treatments · Potassium and Related Disorders

Keywords

Medicine, Internal medicine, Triglyceride, Placebo, Insulin resistance, Lipid profile, Endocrinology, Metabolic syndrome, Cholesterol, Diabetes mellitus, Insulin, Kidney disease, Blood lipids, Gastroenterology, Obesity

MeSH

humans, kidney diseases, cardiovascular diseases, chronic disease, age factors, adult, child, united states

6 authors

From TR

• Ömer ToprakBalıkesir University
• Hüseyin KurtBalıkesir University
• Yasin SarıBalıkesir University
• Cihat ŞarkışBalıkesir University
• Halil UsBalıkesir University
• Ali KırıkBalıkesir University

Abstract

Europe PMC has no abstract for this paper. Open the source to read it.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

Comments

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.